Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 10 | 2023 | 20827 | 0.720 |
Why?
|
Aminopyridines | 1 | 2022 | 543 | 0.640 |
Why?
|
Receptors, Estrogen | 4 | 2022 | 2190 | 0.620 |
Why?
|
Benzimidazoles | 1 | 2022 | 850 | 0.580 |
Why?
|
Brain Neoplasms | 6 | 2023 | 8856 | 0.540 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2022 | 323 | 0.500 |
Why?
|
Receptor, erbB-2 | 8 | 2023 | 2418 | 0.480 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2022 | 539 | 0.470 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5170 | 0.240 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2022 | 11524 | 0.230 |
Why?
|
Receptors, Progesterone | 3 | 2024 | 1098 | 0.180 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2019 | 129 | 0.170 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2023 | 2649 | 0.140 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 487 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2023 | 901 | 0.130 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.130 |
Why?
|
Ovarian Neoplasms | 2 | 2024 | 4839 | 0.130 |
Why?
|
Craniotomy | 1 | 2019 | 729 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5532 | 0.120 |
Why?
|
Piperazines | 1 | 2024 | 2487 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2009 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2924 | 0.110 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 991 | 0.100 |
Why?
|
Mastectomy | 1 | 2019 | 1793 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3480 | 0.090 |
Why?
|
Breast | 1 | 2019 | 1970 | 0.090 |
Why?
|
Caveolin 1 | 1 | 2010 | 263 | 0.080 |
Why?
|
Connective Tissue | 1 | 2010 | 415 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4803 | 0.080 |
Why?
|
Biopsy | 1 | 2019 | 6750 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2529 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9272 | 0.070 |
Why?
|
Prognosis | 3 | 2023 | 29052 | 0.070 |
Why?
|
Female | 10 | 2024 | 380020 | 0.060 |
Why?
|
Humans | 12 | 2024 | 743811 | 0.060 |
Why?
|
Disease Progression | 1 | 2019 | 13273 | 0.050 |
Why?
|
Platinum | 1 | 2024 | 231 | 0.050 |
Why?
|
Phthalazines | 1 | 2024 | 359 | 0.050 |
Why?
|
Camptothecin | 1 | 2023 | 576 | 0.040 |
Why?
|
United States | 2 | 2022 | 69859 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3583 | 0.040 |
Why?
|
Estrogens | 1 | 2024 | 1563 | 0.040 |
Why?
|
Tumor Escape | 1 | 2019 | 350 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2019 | 1880 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 709 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1038 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10251 | 0.030 |
Why?
|
Keratin-6 | 1 | 2010 | 18 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
Keratin-5 | 1 | 2010 | 46 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2019 | 2720 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4477 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2019 | 2988 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11360 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9239 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14714 | 0.020 |
Why?
|
Epithelium | 1 | 2010 | 1679 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40545 | 0.020 |
Why?
|
Macrophages | 1 | 2019 | 5651 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13980 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9440 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2883 | 0.020 |
Why?
|
Middle Aged | 4 | 2020 | 213241 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 77410 | 0.010 |
Why?
|
Aged | 3 | 2020 | 163178 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12788 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6539 | 0.010 |
Why?
|
Adult | 3 | 2019 | 213889 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53250 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 63042 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15067 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2010 | 57744 | 0.000 |
Why?
|
Male | 1 | 2020 | 349776 | 0.000 |
Why?
|
Concepts
(74)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_